This invention relates to novel aryloxypropanolamines. The invention also relates to the pharmaceutically acceptable salts and solvates containing said compounds, methods for the preparation thereof and to respective synthetic intermediates. Said compounds have agonistic activity at .beta.3 adrenergic receptors and are useful for treatment of ailments influenced by activation of .beta.3 adrenergic receptors.